gms | German Medical Science

65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

11. - 14. Mai 2014, Dresden

Identification of prognostic markers in primary glioblastomas with spatial relationship to the subventricular zone

Meeting Abstract

  • Christine Jungk - Neurochirurgische Universitätsklinik, Ruprecht-Karls-Universität Heidelberg
  • Janina Exner - Neurochirurgische Universitätsklinik, Ruprecht-Karls-Universität Heidelberg
  • Andreas Mock - Neurochirurgische Universitätsklinik, Ruprecht-Karls-Universität Heidelberg
  • David Capper - Institut für Neuropathologie, Ruprecht-Karls-Universität Heidelberg
  • Christel Herold-Mende - Neurochirurgische Universitätsklinik, Ruprecht-Karls-Universität Heidelberg
  • Andreas Unterberg - Neurochirurgische Universitätsklinik, Ruprecht-Karls-Universität Heidelberg

Deutsche Gesellschaft für Neurochirurgie. 65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Dresden, 11.-14.05.2014. Düsseldorf: German Medical Science GMS Publishing House; 2014. DocMO.10.02

doi: 10.3205/14dgnc054, urn:nbn:de:0183-14dgnc0544

Veröffentlicht: 13. Mai 2014

© 2014 Jungk et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: We recently reported that contact of primary glioblastoma (GBM) to the subventricular zone (SVZ), the predominant neurogenic region of the adult brain, is associated with increased stem cell marker expression and reduced overall survival (OS). Moreover, mRNA microarray analysis revealed a gene signature distinctive for GBM in contact with the SVZ that was enriched for genes associated with the immune system, developmental pathways and angiogenesis. This analysis aimed at validating single candidate genes with respect to their prognostic impact.

Method: mRNA microarray analysis was conducted from vital tumor samples of 36 GBM with or without contact to the SVZ. R software was used for data processing and statistical analysis. For identification of single genes distinctive of GBM in contact with the SVZ, we investigated genes with the strongest differential expression (p<0.01; fold change(log)>0.5). Validation of localization-dependent expression and evaluation of a potential prognostic impact was done by qPCR in an independent validation set of 145 patients with primary GBM, 98 of them having received intensified treatment (i.e. completion of Stupp regimen). The median was used as the cut-off for grouping into “low” and “high” expression. For survival analysis, a Cox proportional hazard model was employed (univariate (UV); multivariate (MV)).

Results: qPCR analysis of candidate genes in the validation set revealed the prognostic role of 3 genes: High expression of insulin-growth factor binding protein 5 (IGFBP5; linked to tumor dormancy) was associated with inferior OS (p=0.012; UV). In intensively treated patients, high expression of neurotrophic tyrosine kinase receptor type 2 (NTRK2; acting on cell differentiation) was associated with superior OS (p=0.033; UV) and high expression of delta-like ligand 3 (DLL3; a Notch ligand) with inferior OS (p=0.038; UV). In addition, localization-dependent expression of NTRK2 was confirmed in the validation set. After adjustment for known prognostic factors, DLL3 overexpression proved to be an independent prognosticator for inferior OS in a multivariate model (p=0.017; MV).

Conclusions: Validating our candidate genes in an independent study sample revealed the localization-dependent expression of NTRK2. Furthermore, DLL3 was shown to be an independent negative prognosticator. Interestingly, all these genes are associated with stem cell self-renewal, dormancy and differentiation, emphasizing the significance of (cancer) stem cells on the clinical course of GBM.